1. Home
  2. TPST vs ATER Comparison

TPST vs ATER Comparison

Compare TPST & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • ATER
  • Stock Information
  • Founded
  • TPST 2011
  • ATER 2014
  • Country
  • TPST United States
  • ATER United States
  • Employees
  • TPST N/A
  • ATER N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • TPST Health Care
  • ATER Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • ATER Nasdaq
  • Market Cap
  • TPST 27.2M
  • ATER 25.8M
  • IPO Year
  • TPST N/A
  • ATER N/A
  • Fundamental
  • Price
  • TPST $0.89
  • ATER $2.54
  • Analyst Decision
  • TPST Strong Buy
  • ATER Strong Buy
  • Analyst Count
  • TPST 4
  • ATER 1
  • Target Price
  • TPST $20.00
  • ATER N/A
  • AVG Volume (30 Days)
  • TPST 3.3M
  • ATER 47.4K
  • Earning Date
  • TPST 11-12-2024
  • ATER 11-11-2024
  • Dividend Yield
  • TPST N/A
  • ATER N/A
  • EPS Growth
  • TPST N/A
  • ATER N/A
  • EPS
  • TPST N/A
  • ATER N/A
  • Revenue
  • TPST N/A
  • ATER $107,193,000.00
  • Revenue This Year
  • TPST N/A
  • ATER N/A
  • Revenue Next Year
  • TPST N/A
  • ATER $5.45
  • P/E Ratio
  • TPST N/A
  • ATER N/A
  • Revenue Growth
  • TPST N/A
  • ATER N/A
  • 52 Week Low
  • TPST $0.83
  • ATER $0.23
  • 52 Week High
  • TPST $6.00
  • ATER $3.95
  • Technical
  • Relative Strength Index (RSI)
  • TPST 34.45
  • ATER 32.74
  • Support Level
  • TPST $0.94
  • ATER $2.85
  • Resistance Level
  • TPST $1.16
  • ATER $3.10
  • Average True Range (ATR)
  • TPST 0.10
  • ATER 0.19
  • MACD
  • TPST 0.00
  • ATER -0.02
  • Stochastic Oscillator
  • TPST 15.50
  • ATER 0.35

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: